HC Wainwright & Co. Reiterates Neutral on Adicet Bio
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Neutral rating on Adicet Bio (NASDAQ:ACET).

September 19, 2024 | 3:39 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated a Neutral rating on Adicet Bio, indicating no change in their outlook for the company.
The reiteration of a Neutral rating suggests that the analyst does not see significant positive or negative catalysts for Adicet Bio in the short term. This typically implies that the stock is expected to perform in line with the market.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100